No direct interactions inhibit TGF-β expression after dexamethasone treatment in keloids
This study aimed to formulate the Dexamethasone niosome suspension and the suspension was
Dexamethasone is used as an intralesional injection for treating keloids, which is formulated as niosomal gel for the inhibition of keloid fibroblast
Keloids as compared to hypertrophic scars, appear slowly over months, extend beyond the wound causing greater aesthetic disfiguration and discomfort
Dexamethasone significantly suppresses this proangiogenic cytokine compared with Triamcinolone
Patients usually receive a series of injections
Methods: This co-delivery system was prepared with a simple electrospinning technology
7 mg/kg; maximum single dose 36 mg) or multiple doses (0
5 days in the dexamethasone 6 mg arm and 22
No differences between the arms were found for 28- or 90-day mortality
Dexamethasone can affect growth in children
Methods This co-delivery system was prepared with a simple electrospinning technology
1 Materials
The 4 mg/mL strength may also be used for intra-articular, intralesional and soft tissue administration
Results of a multicenter, comparative epidemiological cohort study in Germany
In some cases, surgical approaches are inadvisable, and in such cases, intralesional injection treatments play an important role in the treatment of keloids